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The peptidasic site of highly purified human plasma chohnesterase was investigated using active-site-direct- 
ed inhibitor. Peptidase activity was assayed taking substance P as substrate. Inhibition by organophos- 
phates indicated that the peptidasic site contained an active serine. The presence of essential histidine resi- 
dues associated with serine was revealed by histidine modifications. Carboxyl group reagents showed that 
the active centre contained carboxyl groups in a non-polar environment. The removal of sialic acids did 
not alter peptidase activity. The peptidasic site of cholinesterase shared many properties with serine pro- 
teases ites and esteratic sites of cholinesterases. In addition, with the peptidasic site, as well as the esteratic 
site, there was always the possibility of ‘aging’ when inhibited by DFP or soman. 
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1. INTRODUCTION 
Butyrylcholinesterase (EC 3.1 .1.8) is found in 
plasma as well as in various tissues of vertebrates, 
including nervous structures [l]. BuChE was 
assigned no definite function [2] and its distribu- 
tion in organisms differs from that of 
acetylcholinesterase (EC 3.1.1.7) [ 11. BuChE has 
been revealed in association with secretory pro- 
ducts in the neurohypophysis and hypothalamus 
[3,4], and it has been suggested as a hypothesis that 
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Abbreviations: BuChE, butyrylcholinesterase; AChE, 
acetylcholinesterase; DFP, diisopropyl fluorophosphon- 
ate; DATD, diallyltartardiamide; NANA, N-acetyl- 
neuraminic acid; SP, substance P; 2-PAM, pyridine 
aldoxime methiodide; DEPC, diethylpyrocarbonate; o- 
BAP, w-bromoacetophenone; TLCK, (tosylamido-lf- 
lysine chloromethyl ketone; EDAC, I-ethyl-3-(3-dime- 
thylaminopropyl)carbodiimide; EEDQ, N-ethoxycar- 
bonyl-2-ethoxy-1,2-dihydroquinoline; TMO, trimethyl- 
oxonium; NEM, N-ethylmaleimide 
a neuropeptide could be its endogenous ubstrate 
[5,61. It was demonstrated recently that 
cholinesterases catalyzed the hydrolysis of 
substance P [7,8] and other peptides [9]. Kinetic 
data do not support a role for ChE in substance P 
regulation [7,8,10]. However, studies are too 
fragmentary to allow attribution, or exclusion, of 
a functional significance to the peptidase activity 
of ChE in the processing or termination of the 
biological activity of peptides [ 111. Arguments 
have been presented [ 121 for a physiological role of 
AChE as a peptidase in retinae. 
In a previous work on the peptidase activity of 
human plasma BuChE, we found that sites respon- 
sible for the esterase activity and the SP- 
hydrolyzing property are different [lo]. Here, we 
report further investigations on the nature of the 
peptidasic site of this enzyme. We have undertaken 
amino acid modification to identify this site. Ex- 
periments were carried out on native and 
desialylated BuChE using active-site directed ir- 
reversible inhibitors and other modifiers. Results 
showed that the peptidasic site has structural 
features very similar to those of the esteratic site. 
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2. MATERIALS AND METHODS 
2.1. Enzyme preparation 
BuChE was highly purified from pooled out- 
dated human plasma by the procedure in [ 131 ex- 
cept that ~-mercaptoethanol was omitted in buf- 
fers. The enzyme in solution in 20 mM phosphate 
buffer (pH 6.9) containing 1 mM EDTA (buffer 
A) had a specific activity of 200 ymol. min-’ - 
mgg’ protein. Cholinesterase activity was 
measured as described by Ellman et al. [14] with 
1 mM butyrylthiocholine iodide in 0.1 M phos- 
phate buffer, pH 7, 25°C. The preparation was 
stored at 4°C for several months without loss of 
activity. 
The purified enzyme was considered to be 
homogeneous and free of peptidase contaminants. 
This assumption was supported by the following 
arguments: 
(i) The purification procedure included an af- 
finity chromatography stage on a gel to which pro- 
cainamide, a BuChE ligand, had been coupled. 
(ii) No peptidase activity was found with various 
peptidase substrates: N-benzoyl-L-arginine ethyl 
ester and N-benzoyl-L-tyrosine ethyl ester specific 
for trypsin and chymotrypsin-like proteases 
[ 15,161, Arg-Pro-p-nitranilide for X-prolyldipepti- 
dylaminopeptidases (EC 3.4.14.1) [171, and benzo- 
yloxycarbonyl-sly-Pro-~-nitranilide for prolyl-en- 
dopeptidase (EC 3.4.21.26) [18]. 
(iii) Electrophoretic data of DFP inhibited 
BuChE: 100,J of the preparation were incubated 
with [3H]DFP (4,&i, 50pM final concentration) 
for 24 h at 4°C. Under these conditions, esterase 
and peptidase activities were fully inhibited. Excess 
DFP was removed by continuous dialysis in a 
microcell as in [lo]. Electrophoreses were carried 
out under denaturing and non-denaturing condi- 
tions using a solubilizable polyacrylamide gel (T = 
5,10%) crosslinked with N,N’-diallyltartardi- 
amide in place of methylenebisacrylamide (Bis). 
The molar amount of DATD was 3-times that of 
Bis. After electrophoresis, proteins were first 
stained with Coomassie brilliant blue R-250 [19] 
and then silver-stained [20]. At the same time, 
other gel rods were cut into a-mm thick slices. 
Each slice was placed in a counting vial and in- 
cubated with 1 ml of 2% periodic acid for 10 min 
at room temperature. Scintillation fluid (10 ml of 
Lumagel, Lumac Systems) was then added to each 
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vial and the radioactivity measured in an In- 
tertechnique SL.4000 liquid scintillation spec- 
trometer. Disc electrophoresis of 20 ~1 enzyme per- 
formed according to the standard alkaline discon- 
tinuous system [21] showed a single radioactive 
protein-staining band corresponding to the 
tetrameric form of BuChE (C4 component). SDS- 
electrophoresis with or without ,&-mercaptoethanol 
1191 revealed two radioactive protein-staining 
bands of unequal intensity: the dimer and a trace 
of monomer in the absence of reducing agent, the 
monomer and a minor residual covalent dimer 
113,221 in the presence of ,&mercaptoethanol. 
2.2. Neuraminidase treatment 
N-Acetylneuraminic residues were enzymatically 
removed from the carbohydrate moiety of BuChE. 
150~1 of the preparation were incubated with 
50 mU of a suspension of insolubiIized 
neuraminidase from Clostridium perfringens 
(Sigma type VI-A) at 37°C under gentle stirring. 
The desialylation of BuChE was monitored by 
following the changes in electrophoretic mobility 
on polyacrylamide gel [21]. The reaction was 
stopped after 6 h incubation when no further 
change in the electrophoretic pattern could be 
detected. After treatment, desialylated BuChE was 
separated from neuraminidase by gentle 
centrifugation, 
2.3. Hydrolysis of substance P 
The peptidase activity of BuChE was measured 
with SP (Sigma) as substrate whose concentrations 
ranged from 0.052 to 0.5 mM. BuChE cleaves 3 
peptide bonds of SP successively [S], but only the 
hydrolysis of the first site (Pro’-Lys3) was studied. 
The products of hydrolysis were separated by thin- 
layer chromatography on silica gel. Details of the 
experiment have been given [lo]. 
2.4. ~n~i~~t~on by organ~p~osp~ates 
The enzyme was inhibited by 0.015 mM DFP at 
20°C. Inhibition was carried out for 6 h. Esterasic 
and peptidase activities were measured at various 
times. The enzyme was also inhibited by 0.1 mM 
DFP or soman (pinacolyl methyl fluorophos- 
phonate) until both esterase and peptidase ac- 
tivities were zero. Organophosphate-inhibited 
cholinesterases can be reactivated by treatment 
with nucleophilic reagents. However, inhibited en- 
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zymes become progressively refractory to reactiva- 
tion. This process, called ‘aging’, is due to the 
release of an alkoxy group from the enzyme 
phosphorus moiety [23]. Reactivation of complete- 
ly inhibited activity was attempted, using pyri- 
dinealdoxime methiodide, a potent reactivator: the 
inhibited enzyme was dialyzed continuously in 
dialysis microcell as in [lo] for 3 h against a solu- 
tion of 0.1 M 2-PAM, 50 mM Tris, pH 7.8. 
Esterase and peptidase activities were finally 
measured after a 2 h continuous dialysis against 
buffer A to remove 2-PAM. 
2.5. Chemical modifications 
Chemical modifiers were used to designate 
amino acid residues involved in the peptidasic site 
or located in its immediate environment. The 
chemicals were prepared in buffer A and 100 ~1 en- 
zyme added to 100 ~1 of their solutions. The reac- 
tions took place at 20°C. Excess reagent was 
removed as above prior to substrate hydrolysis. 
2.5.1. Sulfbydryl alkylation 
BuChE was reacted for 2 h with 10 mM N- 
ethylmaleimide. 
2.5.2. Histidine alkylation 
Histidyl residues were modified using diethyl- 
pyrocarbonate and two halomethyl ketones, w- 
bromoacetophenone and (tosylamido-1)lysine 
chloromethylketone. Carbethoxylation of the im- 
idazole ring was continued for I h using 10 mM 
DEPC. The reaction was stopped at the desired 
degree of inactivation by the addition of 30 mM 
imidazole before dialysis. w-BAP or TLCK 
(10 mM) reacted for 2 h with BuChE. After 
dialysis, the modified enzyme was tested for any 
activities remaining. At the same time, reactivation 
of the modified enzyme was attempted by treat- 
ment with nucleophilic reagents: hydroxylamine 
(100 mM) or 2-PAM (40 mM). 
2.5.3. Reactions on carboxyl groups 
BuChE was reacted with 3 carboxyl group 
reagents: 1-ethyl-3-(3-dimethyl~inopropyl)car- 
bodiimide hydrochloride, N-ethoxycarbonyl-2- 
ethoxy-1 ,Zdihydroquinoline and trimethyloxo- 
nium tetrafluoroborate. The enzyme was in- 
cubated with 10 mM EDAC or EEDQ for 6 h. For 
the TM0 reaction, 20-IOOpg reagent were 
weighed out and immediately diluted in an ap- 
propriate volume of the enzymatic preparation at 
O”C, to obtain initial concentrations of TM0 
ranging from 0 to 20 mM. Since the half-life of 
hydrolysis of TM0 was found to be 1.8 min at pH 
7 [24], the effective concentrations of reagent were 
unknown. The reaction was considered to be com- 
plete after 5 min of incubation. 
3. RESULTS AND DISCUSSION 
The present results concerning the effect of 
organophosphate inhibitors and modifiers on the 
SP-hydrolyzing property of BuChE throw some 
light on the nature of the peptidasic site and its sur- 
rounding areas. The main data are summarized in 
table 1. 
Desialylation of BuChE did not induce any 
change in the kinetics of hydrolysis of SP. The ap- 
parent kinetic parameters of the desialylated en- 
zyme for the peptidase activity were the same as 
those of the untreated enzyme. It should be 
remembered that esterase activity of BuChE re- 
mains unchanged after neuraminidase treatment 
[25]. Our result indicates that NANA does not take 
part either in the binding of SP or in the enzymic 
reaction and that modification of the surface of 
BuChE consecutive to desialylation does not alter 
the peptidasic site conformation. 
Esterase activity as well as peptidase activity 
may be inhibited by DFP. However, the rates of 
inhibition of the two activities are widely different 
(fig.1). This result, in agreement with our previous 
results obtained with soman and methanesulfonyl 
fluoride [lo], argues in favour of an active serine 
as the basic residue target at the peptidasic site; 
moreover, it proves that this site is different from 
the esteratic site. The reactivity of the peptidasic 
site with organophosphates i very low compared 
with that of the esteratic site of BuChE, and even 
with that of the active site of various serine pro- 
teases. This could indicate a modification in the 
amino acid arrangement and in the topography of 
the active site compared to other serine proteases. 
But the possibility of a defect in the ‘charge-relay 
system’ must be regarded as has been shown 
recently for tonin, a serine protease which operates 
in the processing of various peptides [26]. Finally, 
treatment of DFP- or soman-inhibited enzyme 
with 2-PAM did not restore the peptidase activity. 
495 
Volume 182, number 2 FEBS LETTERS 
Table 1 
March 1985 
Effect of irreversible inhibitors and amino acid modifiers on peptidase activities of human plasma butyrylcholinesterase 
Reagent (group attacked) 
Neuraminidase (enzymic removal of NANA units) 
Methanesuifonyl fluoride (OH from active serine) 
Soman (OH from active serine) 
Diisopropyl fluorophosphonate 
(OH from active serine) 
~-Ethy~maleimide (SH > NH2) 
Diethylpyrocarbonate (His > NHz) 
w-Bromoacetophenone (His) 
TLCK (His) 
EDAC (COOH > SH, NH2, OH) 
EEDQ (COOH) 
Trimethyloxonium (Glu, Asp) 
Effect on peptidase activity 
no effect 
progressive inhibition [IO] 
progressive inhibition [IO] with aging 
progressive inhibition with aging 
no effect at 10 mM 
progressive inhibition (75070 of inhibition in 
3 min), reactivation by hydroxylamine 
25% of inhibition in 2 h at 10 mM 
100% of inhibition in 2 h at 10 mM 
no effect in 6 h at 10 mM 
75% of inhibition in 4 h at 10 mM 
50% of inhibition in 1 min when initial reagent 
concentration was 12.5 mMa 
100% of inhibition in 1 min when initial reagent 
concentration was 20 mMa 
a Identical effect on the desialylated enzyme 
Act. 9( 
10 
1 al 
1 2 3 4 5 
t (h) 
Fig. 1. Progressive inhibition of peptidase and esterase 
activities of highly purified human plasma 
butyrylcholinesterase (BuChE) by 15 x 10.” M 
This implies that this site is susceptible to aging as 
is the esteratic site. Unfortunately, we have not yet 
any direct evidence for the dealkylation of the 
phosphonylated peptidasic site: after [3H]DFP in- 
hibition, a search for the [3H]isopropyl group, 
removed during the aging process, failed. 
Treatment of BuChE with the sulfydryl reagent 
NEM did not affect peptidase activity. It is unlike- 
ly therefore, that SH groups are essential. On the 
other hand, the existence of histidine associated 
with serine in the charge-relay system was shown. 
Whereas 20 mM DEPC was necessary to inhibit 
50% of the esterase activity in 30 min, more than 
70% of the peptidase activity was inhibited by 
10 mM DEPC in the same time. The progressive 
diisopropyl fluorophosphonate at pH 6.9, 20°C. 
Peptidase activity (e) with substance P (0.25 mM) as 
substrate (rate constant of inhibition kt = 29 x 
10W3 min-‘, bimolecular rate constant kJ[I] = 
196.5 mol-‘.min-‘). Esterase activity (0) with 
butyrylthiocholine (1 mM) as substrate. 
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loss of enzyme activity followed pseudo-first-order 
kinetics; however, the curves showed deviations 
presumably due to hydrolysis of DEPC. For this 
reason, the rate constants were not determined. 
Peptidase activity could be restored by treatment 
with nucleophilic agents. Since hydroxylamine 
removes the carbethoxy group from IV- 
carbethoxyhistidyl residues [27], the inactivation 
of peptidase activity by DEPC may be attributed 
to the modification of an essential histidine. This 
assumption was reinforced by the results of 
halomethyl ketone treatment. At 10 mM, w-BAP 
slightly inactivated the peptidase activity; but at 
the same concentration, TLCK appeared to be a 
more potent inactivator. Once again, reactivation 
of the halomethyl ketone-inhibited enzyme by 
hydroxylamine argues in favour of a modification 
of an active site histidine. 
EDAC (10 mM), a rather hydrophilic water- 
soluble carbodiimide, had no effect on the basal 
peptidase activity. On the other hand, EEDQ and 
TMO, which are less polar, inhibited this activity. 
This fact suggests that the peptidasic site contains 
carboxyl groups in a hydrophobic environment. 
Reactivity to the sterically bulky reagent EEDQ 
points to the relative accessibility of these groups. 
Finally, the fast inactivation of native or 
desialylated enzyme by TM0 confirms that NANA 
units are not involved in the reactivity and confor- 
mation of the peptidasic site. 
In conclusion, the peptidasic site appears to have 
structural features and some properties very 
similar to those of the esteratic site. This finding 
suggests that these sites may perhaps be related. To 
establish their relationship, several hypotheses can 
be proposed as a subject for investigation. The 
first is that these sites are supported by the same 
subunit. In this case, sites may perhaps result from 
gene duplication during evolution. This hypothesis 
is very improbable, because the results of active- 
site titration have shown that the number of pep- 
tidasic sites is very low compared with the number 
of esteratic sites (unpublished). This evidence pro- 
vides support for alternative hypotheses which 
state that these sites are to be found on different 
subunits. It is conceivable that an unknown 
cholinesterase locus, distinct from known ChE 
loci, encodes for an isozyme devoid of 
cholinesterase activity but having peptidase pro- 
perties. This constitutes the isozyme subhypo- 
thesis. However, studies on the peptidase activity 
of BuChE were carried out on enzymes purified 
from pooled plasma ([8], Lockridge, personal 
communication, [IO]} and preparations may con- 
tain a small number of rare cholinesterase variants, 
some of these having peptidase activity. Within the 
framework of this allozyme subhypothesis, the 
peptidasic site should be considered as a mutated 
site rather than another active site. These 
hypotheses are being put to the test in our 
laboratory. 
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